When European patients with urinary tract infections (5) or jejuni and Neisseria cinerea), which can be isolated from those infested with Schistosoma (6) were compared with the human gastro-intestinal tract, were assayed in vitro for healthy controls, the levels of N-nitrosodimethylamine, other their capacity to catalyse N-nitrosation of a series of volatile and non-volatile NOC and nitrite in urine were greatly medicinal drugs and other compounds. Following incubaincreased, particularly in subjects with bacteriuria. Several tion at pH 7.2 in the presence of nitrate (or nitrite) for up bacterial strains that were isolated from urine of infected to 24 (48) h, the yield of N-nitroso compounds (NOC) patients catalysed the nitrosation of morpholine in vitro (7). was quantified by HPLC equipped with a post-column Bacterial catalysis of NOC formation in the stomach and derivatization device, allowing the sensitive detection of urinary bladder has now been demonstrated in vivo in rat acid-labile and acid-stable NOC. Eleven out of the 23 test models (8). Thus, formation of NOC from nitrite and secondary compounds underwent bacteria-catalysed nitrosation by amines by bacteria isolated from various human sources is salivary bacteria, the yield of the respective nitrosation enzyme-mediated (7-12). One of the nitrosating enzymes (pH products varying 800-fold. 4-(Methylamino)antipyrine optimum: 7.25) was purified from P.aeruginosa and N.mucosa exhibited the highest rate of nitrosation, followed by dichlo-(13) and characterized to be cd 1 -nitrite reductase (14,15). The fenac Ͼ metamizole Ͼ piperazine Ͼ five other drugs, whilst results indicate that bacteria possessing nitrate reductase and L-proline and L-thioproline had the lowest nitrosation nitrosating enzymes can contribute to NOC formation in vivo, rate. Ten drugs including aminophenazone, cimetidine when precursors are available. Nitrosatable precursors are and nicotine, did not inhibit bacterial growth, allowing present in normal Western diet (16), but larger amounts of transitory nitrite to be formed, but no N-nitroso derivatives nitrosatable drugs are often taken orally for medication several were detected. Three drugs inhibited the proliferation of times a day after meals. Thus, after reaching the stomach these bacteria and neither nitrite nor any NOC were formed. drugs could undergo chemical or bacteria-catalysed nitrosation, Using metamizole as an easily nitrosatable precursor, two depending on (a) the stomach pH, (b) the degree of colonization strains, Campylobacter jejuni and Helicobacter pylori, were of the (achlorhydric) stomach by bacteria and (c) the nitrate shown to catalyse nitrosation in the presence of nitrite at content of the diet. Nitrosation in vivo could be shown in a pH 7.2. As compared to Neisseria cinerea used as a healthy human volunteer living on Western diet, whereby upon nitrosation-proficient control strain, H.pylori was 30-100 ingestion of metamizole the unmetabolized nitrosated product times less effective, whilst C.jejuni had intermediary N-nitroso-4-(methylamino)antipyrine was detected in urine activity. The results of our sensitive nitrosation assay (17). Using a standardized sensitive method to simulate in vivo further confirm that bacteria isolated from human sources, nitrosation conditions we examined the capacity of micropossessing nitrate reductase and/or nitrosating enzymes organisms from human saliva to catalyse N-nitrosation of a such as cytochrome cd 1 -nitrite reductase (Calmels et al., series of mostly medicinal drugs. Using metamizole [or its Carcinogenesis, 17, 533-536, 1996), can contribute to intrametabolite 4-(methylamino)antipyrine] as most readily nitrosatgastric nitrosamine formation in the anacidic stomach when able substrate in the presence of nitrite, the nitrosating capacity nitrosatable precursors from exogenous and endogenous of strains previously isolated from the human gastro-intestinal sources are present.
is now supported by studies using analytical methods Micro-organisms commonly present in human saliva and and storage conditions that exclude artifactual NOC formation.
three DSM strains (Helicobacter pylori, Campylobacter
When European patients with urinary tract infections (5) or jejuni and Neisseria cinerea), which can be isolated from those infested with Schistosoma (6) were compared with the human gastro-intestinal tract, were assayed in vitro for healthy controls, the levels of N-nitrosodimethylamine, other their capacity to catalyse N-nitrosation of a series of volatile and non-volatile NOC and nitrite in urine were greatly medicinal drugs and other compounds. Following incubaincreased, particularly in subjects with bacteriuria. Several tion at pH 7.2 in the presence of nitrate (or nitrite) for up bacterial strains that were isolated from urine of infected to 24 (48) h, the yield of N-nitroso compounds (NOC) patients catalysed the nitrosation of morpholine in vitro (7) . was quantified by HPLC equipped with a post-column
Bacterial catalysis of NOC formation in the stomach and derivatization device, allowing the sensitive detection of urinary bladder has now been demonstrated in vivo in rat acid-labile and acid-stable NOC. Eleven out of the 23 test models (8) . Thus, formation of NOC from nitrite and secondary compounds underwent bacteria-catalysed nitrosation by amines by bacteria isolated from various human sources is salivary bacteria, the yield of the respective nitrosation enzyme-mediated (7) (8) (9) (10) (11) (12) . One of the nitrosating enzymes (pH products varying 800-fold. 4-(Methylamino)antipyrine optimum: 7.25) was purified from P.aeruginosa and N.mucosa exhibited the highest rate of nitrosation, followed by dichlo- (13) and characterized to be cd 1 -nitrite reductase (14, 15) . The fenac Ͼ metamizole Ͼ piperazine Ͼ five other drugs, whilst results indicate that bacteria possessing nitrate reductase and L-proline and L-thioproline had the lowest nitrosation nitrosating enzymes can contribute to NOC formation in vivo, rate. Ten drugs including aminophenazone, cimetidine when precursors are available. Nitrosatable precursors are and nicotine, did not inhibit bacterial growth, allowing present in normal Western diet (16) , but larger amounts of transitory nitrite to be formed, but no N-nitroso derivatives nitrosatable drugs are often taken orally for medication several were detected. Three drugs inhibited the proliferation of times a day after meals. Thus, after reaching the stomach these bacteria and neither nitrite nor any NOC were formed. drugs could undergo chemical or bacteria-catalysed nitrosation, Using metamizole as an easily nitrosatable precursor, two depending on (a) the stomach pH, (b) the degree of colonization strains, Campylobacter jejuni and Helicobacter pylori, were of the (achlorhydric) stomach by bacteria and (c) the nitrate shown to catalyse nitrosation in the presence of nitrite at content of the diet. Nitrosation in vivo could be shown in a pH 7.2. As compared to Neisseria cinerea used as a healthy human volunteer living on Western diet, whereby upon nitrosation-proficient control strain, H.pylori was 30-100 ingestion of metamizole the unmetabolized nitrosated product times less effective, whilst C.jejuni had intermediary N-nitroso-4-(methylamino)antipyrine was detected in urine activity. The results of our sensitive nitrosation assay (17) . Using a standardized sensitive method to simulate in vivo further confirm that bacteria isolated from human sources, nitrosation conditions we examined the capacity of micropossessing nitrate reductase and/or nitrosating enzymes organisms from human saliva to catalyse N-nitrosation of a such as cytochrome cd 1 -nitrite reductase ( . Pure drugs were extracted from commerically available preparations and purified by recrystallization, others were donated by the manufacturerers. All other chemicals were of analytical grade purity and were obtained from commercial sources.
Micro-organisms
Micro-organisms from saliva samples were collected each time from the same healthy volunteer. Strains that proliferated under the conditions of the nitrosation assay were mainly α-haemolytic streptococci, in addition, β-haemolytic streptococci, Neisseria, staphylococci and corynebacteria were present. The microbiological characterization of these strains was carried out by Professor Dr K.Wettig (Forschungsstelle Berlin-Buch des Forschungs- 
Extraction of NOC Assay medium
An Extrelut ® 20 column was packed with 2 g of a mixture of equal weight The incubation medium for the nitrosation assay with salivary bacteria parts of Extrelut/ascorbic acid (finely powdered, high-purity grade), then 2 g consisted of 14.25 g glucose broth (SIFIN, Berlin) that was dissolved in of a mixture of equal weight parts of Extrelut/sodium sulphate (anhydrous, 450 ml dist. water, and adjusted to pH 7.2 by adding 0.5 M Na 3 PO 4 solution.
finely powdered, high-purity grade) and 10-14 g (depending on the volume The solution was then poured into a DURAN ® bottle with screw cap and of the sample) of Extrelut. 5, 10 or 20 ml of the incubation medium silicone gasket, containing a magnetic stirrer, and autoclaved. 8.9 g Na 2 HPO 4 were applied to the packed column and extracted three times with 20 ml . 2 H 2 O, 504.4 mg KNO 3 (0.004 mol), and 0.001 mol of the nitrosatable test dichloromethane each.The combined extracts were concentrated to 1 ml or to compound were dissolved in 40 ml dist. water, adjusted to pH 7.2 by adding dryness under vacuum. The extraction procedure was validated using the polar 0.5 M H 3 PO 4 , subjected to sterile filtration through a membrane filter, made compounds proline and thioproline as substrates in the nitrosation assay. up to 50 ml and added to the autoclaved, cooled glucose broth under Artifactual nitrosation is inhibited by borate addition to stop nitrosation. The sterile conditions. purpose of the Extrelut/ascorbic acid layer is to remove amines from the eluate. Nitrosation assay for salivary bacteria. Freshly collected saliva (3-4 ml) was
Quantitative determination of N-nitroso compounds added to the incubation medium at 37°C under aerobic conditions and constant
Method A: determination of total N-nitroso compounds. One millilitre of the stirring, and then incubated for 24 h. During the first 12 h, aliquots were concentrated dichloromethane extract was mixed with 2 ml of 0.2 M hydrogen taken every 60 min; the last sample was taken at the end of incubation after bromide in glacial acetic acid (18) . After 15 min, 2 ml colorimetric reagent 24 h. The samples were then assayed for their content of nitrite and N-nitroso IA (2 g sulphanilic acid and 75 ml glacial acetic acid made up to 150 ml compounds (NOC). The pH and turbidity were determined. Three millilitres with distilled water) was added and after 10 min, colorimetric reagent II to of the sterile sample was added into a 1-cm cuvette and the absorbance at make up to 5 ml. After an additional 10 min the absorbance was measured at λ ϭ 680 nm was taken as a qualitative indicator of bacterial proliferation.
λ ϭ 540 nm. After determination of turbidity, the pH of the bacterial suspension was
Method B: analysis of acid-labile N-nitroso compounds. The dry dichloromeasured with a micro-electrode directly in the cuvette. methane extract was dissolved in 1000 µl solvent (acetonitrile/water, 30/70 Nitrosation assay of metamizole in the presence of strains from the gastroby vol.). Aliquots of 100 µl were injected and chromatographed on intestinal tract. A mixture of 50 ml brucella broth (Difco Laboratories, HPLC (Figure 1 ) without photoreactor at a flow rate of 0.5 ml/min. Colorimetric Detroit), 3.5 ml foetal calf serum (Gibco/BRL, Life Technologies, Paisley), reagent III was added behind the column at a flow rate of 0.1 ml/min. The 0.5, 1.0 or 2.0 ml nitrosating mixture (containing 0.5, 1.0 or 2.0 µmol nitrite colorimetric reagent III was prepared as follows: 700 mg sulphanilamide, and metamizole) was inoculated with 2 ml culture medium of Campylobacter 100 mg N-(1-naphthyl)ethylenediamine dihydrochloride, 60 ml of acetonitrile/ jejuni, Helicobacter pylori and Neisseria cinerea harvested from plates with water (30/70 by vol.) and 6 ml 47% hydrobromic acid were made up to Columbia-EH agar (Difco Laboratories, Detroit) supplemented with lysated 200 ml with distilled water. Activated charcoal was added to the solution horse blood. This was pre-incubated for 3 days with the respective bacteria which was then kept at 0-4°C in the dark. Before use the reagent was filtered in a micro-aerobic environment; the latter was generated by Anaerocult ® through a glass fibre filter. Acid-labile N-nitroso compounds were hydrolysed C-Merck. The incubation medium was shaken at 37°C under micro-aerobic at 95°C in the reaction coil. N 2 O 3 released by hydrolysis reacted with conditions. After 48 h, the incubation was stopped by adding 2.5 g sodium sulphanilamide to give the respective diazo compound that coupled with Ntetraborate. For NOC determination 20 ml of the culture medium was extracted
(1-naphthyl)ethylenediamine. The corresponding azo dye was quantified at by the Extrelut method and N-nitroso-4-(methylamino)antipyrine determined λ ϭ 540 nm. by high performance liquid chromatography (HPLC) as described below.
Method B1: analysis of acid-stable N-nitroso compounds. Aliquots of 100 µl Analysis of nitrite of the dichloromethane extract dissolved in solvent (acetonitrile/water, 30/70 One-millilitre aliquots of the incubation medium were added into an Eppendorf by vol.) were injected and chromatographed at a flow rate of 0.5 ml/min on tube containing 200 mg powdered Na 2 B 4 O 7 ·10 H 2 O. The tube was closed the HPLC (Figure 1 ) that contained a photoreactor. In the photoreactor the tightly and shaken well. Until measurement the samples remained N-nitroso compounds were subjected to photolysis. Behind the photorefrigerated. The suspension was then centrifuged and 100 µl of the superreactor the colorimetric reagent III was mixed to the eluent at a flow rate of natant added to 4.5 ml of colorimetric reagent I. Two grams of sulphanilic 0.1 ml/min. The azo dye formed in the reaction coil at 60°C was quantified acid, 50 ml glacial acetic acid and 6 ml 47% hydrobromic acid were made by measuring the absorbance at λ ϭ 540 nm. up to 500 ml with distilled water, shaken well and left at ambient temperature in a tightly sealed glass tube of ground glass for 10 min. Thereafter,
Results

colorimetric reagent II 250 mg N-(1-naphthyl)ethylenediamine dihydrochloride (Bratton-Marshall reagent) and 75 ml glacial acetic acid made up with distilled
The chemical formulae of the drugs and chemicals tested in water to 250 ml; the solution was kept at 0-4°C prior to use) was added to the bacterial nitrosation assay are shown in Figure 2 . These give 5 ml final volume. After 10 min at room temperature, the absorbance was colorimetrically determined at λ ϭ 540 nm.
compounds were selected because all are known from the Table I ); all compounds are known from the literature to be nitrosatable acidified nitrite by nitrite (N 2 O 3 ) at acidic pH. literature to be nitrosatable by acidified nitrite. A typical Upon incubation of compounds nos 12-19 (Table I) in the presence of NO 3 -and salivary bacteria, the micro-organisms example for the time course of nitrosation by salivary bacteria in the presence of nitrate and 4-(methylamino)antipyrine is proliferated, allowing transitory formation of nitrite. NOC were not formed in any case, although these precursor compounds are shown in Figure 3 .
In a typical experiment, bacteria started to proliferate known to be nitrosatable by acidified nitrite. This group included the H 2 -blocker cimetidine, the secondary amines exponentially after a short initial lag phase and then absorbance at λ ϭ 680, a measure of bacterial density increased dimethyl-and di-isopropylamine, as well as the tertiary amino group-containing aminophenzone and nicotine. Only three steadily. The pH only changed from 7.4 to 7.2, but never fell to an acidic range during a 24-h incubation period. Nitrate drugs (nos 21-23) each containing nitrosatable amino groups inhibited bacterial proliferation, and as a consequence neither was reduced to nitrite by bacterial enzymes most actively during the exponential growth phase. After 6 h, a peak nitrite nitrite nor any NOC were detectable. Bacterial strains from the human gastro-intestinal tract, concentration was reached which decreased thereafter. In proportion to a decrease in nitrite concentration, increasing
Helicobacter pylori and Campylobacter jejuni (obtained from Deutsche Sammlung von Mikroorganismen, Braunschweig, amounts of N-nitroso-4-(methylamino)antipyrine were formed.
Using this sensitive assay for simulating in vivo nitrosation Germany) were compared to Neisseria cinerea (DSM 4630). Neisseria strains present in human saliva were previously conditions at pH 7.2 (molar ratio of drug:nitrate ϭ 1:4), 11 out of 23 test compounds underwent bacteria-catalysed shown to possess nitrosating activity (13) . Nitrosation assays were carried out according to procedure B (Materials and nitrosation to yield the respective acid-stable or acid-labile Nnitroso compound (Table I , nos 1-11). Nitrosation rates, i.e. methods), using a molar ratio of nitrite:metamizole ϭ 1:1 and 48 h of incubation under micro-aerobic conditions. Taking yield of NOC after 24 h of incubation, varied 800-fold with 4-(methylamino)antipyrine being most rapidly nitrosated and the absorbance of the incubation media at λ ϭ 720 nm (1-cm cuvette) as an indicator of bacterial proliferation, the L-thioproline having the lowest rate. same value of 0.800 was recorded in all the experiments contain nitrate-and nitrite-reducing species, and can catalyse involving the above strains. The pH values always ranged the formation of NOC from a series of drugs or compounds between 7.2 and 7.8. All three strains yielded detectable that contain a nitrosatable amino group. Among the 23 test amounts of N-nitroso-4-(methylamino)antipyrine, whereby compounds, 11 underwent bacteria-catalysed nitrosation by the yield increased as a function of precursor concentration salivary bacteria. However, under standard assay conditions (Figure 4) . the yield of the respective N-nitrosated product varied by two Under our assay conditions the yield of NOC was highest in orders of magnitude. 4-(Methylamino)antipyrine exhibited the the presence of Neisseria cinerea, followed by Campylobacter highest nitrosation rate and L-thioproline the lowest. Thirteen jejuni (strain DSM 4688), but was 30-100 times lower with drugs including the H 2 -blocker cimetidine and nicotine did not Helicobacter pylori (strain DSM 4867). The weak nitrosation yield any NOC under our assay conditions. As all test comactivity of this Helicobacter pylori strain was confirmed in a pounds are known from the literature to be nitrosated by series of 72-h incubation assays with different amounts of acidified nitrite, our data revealed that the yield of nitrosated nitrite, using metamizole, a rapidly nitrosatable precursor. The products by bacterial catalysis does not parallel that of the yield of N-nitroso-4-(methylamino)antipyrine was up to 200 chemical nitrosation. Previous investigations on the bacteriatimes higher than in the control assays where bacteria had catalysed formation of NOC revealed that the nitrosation been omitted (Figure 5 ), confirming that bacteria-catalysed activity in non-denitrifying bacterial strains like E.coli was nitrosation reaction has occurred under these conditions. associated with nitrate reductase, while in denitrifying bacteria such as Neisseria mucosa and Pseudomonas aeruginosa (isolDiscussion ated from gastric juice of achlorhydric patients) nitrosation capacity was linked to nitrite reductase) (20) . Recently, the The composition of the microflora present in the oral cavity identification of cytochrome cd 1 -nitrite reductase (14) as one shows great inter-individual variations but seems to be constant of the enzymes responsible for catalysis of nitrosation has in a human subject over a longer time period (19) . Using a been reported (15) . The production of nitric oxide (NO) or sensitive in vitro assay for the nitrosation capacity of
[NO] ϩ -like species from nitrite has been proposed which bacteria (pH 7.2) in the presence of nitrate or nitrite, HPLC were also generated from non-denitrifying enteric bacteria like quantification combined with a post-column derivatization E.coli or Proteus morganii. This confirms earlier observations method allowed the detection of acid-labile or acid-stable on the reduction of nitrite to nitric oxide (NO) by enteric NOC generated. Our results (Table I) confirm that bacteria from human saliva (collected repeatedly from the same volunteer) bacteria (21) . Under aerobic conditions NO is oxidized to form NO 2 that exists in equilibrium with potent nitrosating agents reactions occur in the human stomach (23) . Studies including several hundred untreated patients categorized by diagnosis to N 2 O 3 and N 2 O 4 , which react at neutral pH with (secondary) amines to form N-nitroso compounds. It is very likely that be at greater risk of developing gastric cancer, including patients with chronic atrophic gastritis, partial gastrectomy NO or [NO] ϩ -like species are also produced under our assay conditions from various bacterial strains present in human and pernicious anaemia, showed significantly higher nitrite and total nitroso compound concentrations in the gastric juice. saliva. Here, the situation is more complex in that a mixture of nitrate-reducing strains devoid of nitrosation activity As in these patients the second peak concentration of nitroso compounds was found at pH 7 of the gastric juice, it strongly together with strains that have both enzymatic properties may coexist. This may account for the observed differences;
suggests that bacteria-catalysed nitrosation is the origin of these nitrosated products. As found earlier, 25 out of 38 concerning the nitrosation reaction and substrate specificity. E.coli strains nitrosated secondary amines with a rate that organisms isolated from diverse human sources including gastric juice from achlorhydric patients and subjects with was inversely related to their pK a value; morpholine and Lthioproline were readily nitrosated and dimethylamine less fast urinary tract infections were able to catalyse nitrosation in vitro at pH 7.2, including most of the E.coli strains as well as other (10) . Although the incubation conditions in our assay with salivary bacteria were not identical, dimethylamine was not species (7) . Taking advantage of the sensitivity of our in vitro found to be nitrosated, while the nitrosation yield for thioproline was 800 times lower than for the fastest nitrosatable precursor nitrosation assay using metamizole as a most readily nitrosatable substrate, we investigated the nitrosation catalysis by 4-(methylamino)antipyrine (Table I) .
The bacterially catalysed nitrosation of drugs that we have strains that can be isolated from the human gastro-intestinal tract, i.e. Campylobacter jejuni and Helicobacter pylori. Both demonstrated to occur in vitro yielding in some instances carcinogenic nitroso compounds (reviewed in 22), may strains in the presence of nitrite were compared for their nitrosation capacity with Neisseria cinerea, a species known probably not occur in substantial amounts in healthy subjects. Even when saliva is swallowed, bacteria are immediately to contain a high nitrosation capacity-likely due to the presence of cytochrome cd 1 -nitrite reductase-as previously killed by hydrochloric acid in the stomach. However, in patients with chronic gastric achlorhydria causing bacteria shown for Neisseria mucosa (15) . When comparing these three strains, Campylobacter jejuni showed intermediate colonization, nitrosation of precursors arising from the diet, of amines produced by physiological metabolism or of ingested nitrosation capacity, while the Helicobacter strain DSM 4867 gave only 30-100 times lower nitrosation yield as found for drugs could be substantial. Indeed, recent results confirm that both acid-catalysed and bacteria-catalysed N-nitrosation Neisseria. Because of the very similar incubation conditions for all three strains, the difference in yield of N-nitroso-4-(nitrosamino)antipyrine must be attributed to their different 
